EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy

Charlotte Falke iD, Fatma Karapinar iD, Marcel Bouvy iD, Mariëlle Emmelot iD, Svetlana Belitser iD, Benoit Boland iD, Denis O'Mahony iD, Kevin D Murphy iD, Moa Haller iD, Paola Salari iD, Matthias Schwenkglenks iD, Nicolas Rodondi iD und 2 weitere

European Geriatric Medicine · 2024

DOI: 10.1007/s41999-024-01036-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Geriatric Medicine, 2024. Verfasst von Charlotte Falke und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Ut…. Hauptthemen laut MEDLINE: Quality of Life, Polypharmacy, Multimorbidity. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To explore the association between medication use-related factors and health-related quality of life (HRQoL) in older hospitalised multimorbid patients with polypharmacy.

Methods

This cross-sectional study used the intervention arm data of the OPERAM trial (hospitalised patients ≥ 70 years with polypharmacy). HRQoL was assessed using the visual analogue scale (EQ-VAS) and the EQ-5D index score of the EuroQol questionnaire (EQ-5D-5L). Lower or higher EQ-VAS/EQ-5D was based on the median of the study population. Medication use-related factors included hyperpolypharmacy (≥ 10 medications), anticholinergic and sedative burden, appropriateness of medication (STOPP/START criteria), high-risk medication for hospital (re)admission, medication complexity and adherence. Multivariable logistic regression analysis was used to assess the association between medication use-related factors and HRQoL.

Results

A total of 955 patients were included (mean age 79 years, 46% female, median EQ-VAS of 60, median EQ-5D of 0.60). Opioids use was associated with lower EQ-5D and EQ-VAS (aOR EQ-5D: 2.10; 95% CI 1.34–3.32, EQ-VAS: 1.59; 1.11–2.30). Hyperpolypharmacy (aOR 1.37; 1.05–1.80), antibiotics (aOR 1.64; 1.01–2.68) and high medication complexity (aOR 1.53; 1.10–2.15) were associated with lower EQ-VAS. A high anticholinergic and sedative burden (aOR 1.73; 1.11–2.69), presence of multiple prescribing omissions (aOR 1.94; 1.19–3.17) and benzodiazepine use (aOR 2.01; 1.22–3.35) were associated with lower EQ-5D. Especially in hyperpolypharmacy patients, high anticholinergic and sedative burden and medication complexity were associated with a lower HRQoL.

Conclusion

Several medication use-related factors are significantly associated with a lower HRQoL in hospitalised older patients. Medication complexity is a novel factor, which should be considered when evaluating medication use of older patients with hyperpolypharmacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifePolypharmacyMultimorbidityHumansFemaleMaleAgedCross-Sectional StudiesAged, 80 and overSurveys and QuestionnairesHospitalizationCholinergic Antagonists

Stichwörter der Autor:innen

HRQoLMedication complexityMedication usePolypharmacyQuality of life

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. c.m.falke@uu.nl.
  • Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Department of Clinical Pharmacy, CARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • Geriatric Medicine Department and Expertise Centre Pharmacotherapy in Old Persons, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Institute of Health and Society (IRSS), Université Catholique de Louvain (UCLouvain), Louvain, Belgium.

ORCID-Profile: Charlotte Falke, Fatma Karapinar, Marcel Bouvy, Mariëlle Emmelot, Svetlana Belitser, Benoit Boland, Denis O'Mahony, Kevin D Murphy, Moa Haller, Paola Salari, Matthias Schwenkglenks, Nicolas Rodondi, Toine Egberts, Wilma Knol

Zitieren

APA

Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O'Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine. https://doi.org/10.1007/s41999-024-01036-4

Vancouver

Falke C, Karapinar F, Bouvy M, Emmelot M, Belitser S, Boland B, et al. The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine. 2024. doi:10.1007/s41999-024-01036-4

BibTeX
@article{Falke2024,
  author = {Falke, Charlotte and Karapinar, Fatma and Bouvy, Marcel and Emmelot, Mariëlle and Belitser, Svetlana and Boland, Benoit and O'Mahony, Denis and Murphy, Kevin D and Haller, Moa and Salari, Paola and Schwenkglenks, Matthias and Rodondi, Nicolas and Egberts, Toine and Knol, Wilma},
  title = {The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy},
  journal = {European Geriatric Medicine},
  year = {2024},
  doi = {10.1007/s41999-024-01036-4}
}
Kostenlos starten →